BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19208587)

  • 21. Biologic agents in the treatment of rheumatic diseases with chronic viral infection. Where are we?
    Wendling D; Di Martino V; Herbein G
    J Rheumatol; 2009 Jun; 36(6):1107-8. PubMed ID: 19509089
    [No Abstract]   [Full Text] [Related]  

  • 22. Cryptococcal prostatitis in a patient with chronic lymphocytic leukemia.
    Sharma N; Varma S; Varma N; Kumari S; Chakraborty A
    J Assoc Physicians India; 2000 Oct; 48(10):1015-6. PubMed ID: 11200902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary infection with Cryptococcus neoformans in the face of underlying sarcoidosis.
    Boyton RJ; Altmann DM; Wright A; Kon OM
    Respiration; 2007; 74(4):462-6. PubMed ID: 16106116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacologic treatment of sarcoidosis].
    Cîlţ C
    Pneumologia; 2005; 54(2):66-71. PubMed ID: 16536004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disseminated Salmonella typhimurium infection secondary to infliximab treatment.
    Fu A; Bertouch JV; McNeil HP
    Arthritis Rheum; 2004 Sep; 50(9):3049. PubMed ID: 15457476
    [No Abstract]   [Full Text] [Related]  

  • 26. Disseminated Cryptococcus infection in a liver-transplant recipient presenting with a chronic scalp eruption.
    Ladoyanni E; Pereira M; Struthers K; Chen K; Haydon G; Mutimer D; Elias E; Ilchyshyn A
    Clin Exp Dermatol; 2008 Aug; 33(5):655-6. PubMed ID: 18616727
    [No Abstract]   [Full Text] [Related]  

  • 27. Sarcoidosis with cryptococcal infection apparently engaging only immune-privileged body compartments: a case report.
    van der Stoep JH; Sigstad E; Bredberg A
    BMC Infect Dis; 2020 Jun; 20(1):440. PubMed ID: 32571242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infection and anti-tumor necrosis factor-alpha therapy.
    Zandman-Goddard G
    Isr Med Assoc J; 2003 Nov; 5(11):814-6. PubMed ID: 14650109
    [No Abstract]   [Full Text] [Related]  

  • 29. Tzanck smear as a rapid diagnostic tool for disseminated cryptococcal infection.
    Fridlington E; Colome-Grimmer M; Kelly E; Kelly BC
    Arch Dermatol; 2006 Jan; 142(1):25-7. PubMed ID: 16415382
    [No Abstract]   [Full Text] [Related]  

  • 30. The increasing prevalence of listeriosis--what are we missing?
    Khatamzas E; Hughes H; Grant KA; McLauchlin J; Bowler IC
    QJM; 2010 Jul; 103(7):519-22. PubMed ID: 20042433
    [No Abstract]   [Full Text] [Related]  

  • 31. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
    Aringer M; Houssiau F; Gordon C; Graninger WB; Voll RE; Rath E; Steiner G; Smolen JS
    Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacotherapy of cryptococcosis.
    Ritter M; Goldman DL
    Expert Opin Pharmacother; 2009 Oct; 10(15):2433-43. PubMed ID: 19708853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequestration of active Cryptococcus neoformans infection in the parathyroid gland despite prolonged therapy in a renal transplant recipient.
    Thalla R; Kim D; Venkat KK; Parasuraman R
    Transpl Infect Dis; 2009 Aug; 11(4):349-52. PubMed ID: 19422668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fungal infections as a complication of therapy for sarcoidosis.
    Baughman RP; Lower EE
    QJM; 2005 Jun; 98(6):451-6. PubMed ID: 15879444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infectious complications of biologic agents.
    Martin-Mola E; Balsa A
    Rheum Dis Clin North Am; 2009 Feb; 35(1):183-99. PubMed ID: 19481004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pericardial effusions on anti-TNF therapy for rheumatoid arthritis--a drug side effect or uncontrolled systemic disease?
    Edwards MH; Leak AM
    Rheumatology (Oxford); 2009 Mar; 48(3):316-7. PubMed ID: 19106166
    [No Abstract]   [Full Text] [Related]  

  • 37. Cryptococcosis in sarcoidosis: cryptOsarc, a comparative study of 18 cases.
    Bernard C; Maucort-Boulch D; Varron L; Charlier C; Sitbon K; Freymond N; Bouhour D; Hot A; Masquelet AC; Valeyre D; Costedoat-Chalumeau N; Etienne M; Gueit I; Jouneau S; Delaval P; Mouthon L; Pouget J; Serratrice J; Brion JP; Vaylet F; Bremont C; Chennebault JM; Jaffuel S; Broussolle C; Lortholary O; Sève P;
    QJM; 2013 Jun; 106(6):523-39. PubMed ID: 23515400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential biomarkers of monocyte/macrophage activity in a patient with sarcoidosis, treated with infliximab.
    Fang B; Bhagat S; Busch R; Parfrey H; Hall FC
    Rheumatology (Oxford); 2011 May; 50(5):992-4. PubMed ID: 21278065
    [No Abstract]   [Full Text] [Related]  

  • 39. Two cases of serious food-borne infection in patients treated with anti-TNF-alpha. Are we doing enough to reduce the risk?
    Makkuni D; Kent R; Watts R; Clunie G
    Rheumatology (Oxford); 2006 Feb; 45(2):237-8. PubMed ID: 16377730
    [No Abstract]   [Full Text] [Related]  

  • 40. Pulsating back pain associated with tumor necrosis factor-alpha blockade.
    Rozin AP; Braun-Moscovici Y; Balbir-Gurman A
    Ann Pharmacother; 2008 Dec; 42(12):1912-3. PubMed ID: 19033477
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.